These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3332191

  • 1. Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654).
    Skórski T, Kawalec M.
    Bone Marrow Transplant; 1987 Dec; 2(4):435-40. PubMed ID: 3332191
    [Abstract] [Full Text] [Related]

  • 2. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide.
    Skórski T, Kawalec M.
    Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130
    [Abstract] [Full Text] [Related]

  • 3. Early induction of immune resistance against leukemia in lethally total body irradiated mice reconstituted with syngeneic bone marrow cells obtained from previously immunized donor mice.
    Skorski T, Kawalec M, Kawiak J.
    Bone Marrow Transplant; 1990 Jan; 5(1):23-7. PubMed ID: 2297588
    [Abstract] [Full Text] [Related]

  • 4. The kinetics of immunologic and hematologic recovery in mice after lethal total body irradiation and reconstitution with syngeneic bone marrow cells treated or untreated with mafosfamide (ASTA Z 7654).
    Skórski T, Kawalec M, Hoser G, Ratajczak M, Gnatowski B, Kawiak J.
    Bone Marrow Transplant; 1988 Nov; 3(6):543-51. PubMed ID: 2905613
    [Abstract] [Full Text] [Related]

  • 5. Induction of immune resistance against L1210 lymphatic leukemia in mice after lethal irradiation and reconstruction with fetal liver cells.
    Skórski T, Ratajczak MZ, Kawalec M, Kawiak J.
    Folia Histochem Cytobiol; 1991 Nov; 29(3):121-4. PubMed ID: 1794437
    [Abstract] [Full Text] [Related]

  • 6. Early induction of immune resistance against leukemia in mice after lethal irradiation followed by syngeneic bone marrow transplantation and injection of syngeneic leukocytes.
    Skórski T, Kawalec M, Kawiak J.
    Transplantation; 1991 Apr; 51(4):843-7. PubMed ID: 2014540
    [Abstract] [Full Text] [Related]

  • 7. Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells.
    Kawalec M, Skórski T, Kawiak J.
    Invest New Drugs; 1988 Sep; 6(3):169-72. PubMed ID: 3192382
    [Abstract] [Full Text] [Related]

  • 8. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.
    Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A.
    J Immunol; 1992 Mar 15; 148(6):1693-8. PubMed ID: 1541813
    [Abstract] [Full Text] [Related]

  • 9. New application of a stabilized active cyclophosphamide derivative (mafosfamide, ASTA Z 7654)--immunogenic properties of lymphatic leukemia L 1210 cells treated in vitro with the drug.
    Skórski T, Kawalec M.
    Invest New Drugs; 1987 Mar 15; 5(2):167-9. PubMed ID: 3654151
    [Abstract] [Full Text] [Related]

  • 10. Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z).
    Weiss L, Slavin G, Reich S, Sidi H, Slavin S.
    Bone Marrow Transplant; 1994 Jan 15; 13(1):27-30. PubMed ID: 8019450
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Casorati G, Locatelli F, Pagani S, Garavaglia C, Montini E, Lisini D, Turin I, Rossi F, Dellabona P, Maccario R, Montagna D.
    Exp Hematol; 2005 Feb 15; 33(2):212-8. PubMed ID: 15676215
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
    Jiang R, Bony V, Lopez M.
    Prog Clin Biol Res; 1994 Feb 15; 389():23-9. PubMed ID: 7700906
    [No Abstract] [Full Text] [Related]

  • 13. Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice.
    Huss R, Beckham C, Storb R, Deeg HJ.
    Transplantation; 1994 Dec 27; 58(12):1366-71. PubMed ID: 7809930
    [Abstract] [Full Text] [Related]

  • 14. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays.
    Jones RJ, Colvin OM, Sensenbrenner LL.
    Cancer Res; 1988 Jun 15; 48(12):3394-7. PubMed ID: 3285994
    [Abstract] [Full Text] [Related]

  • 15. Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1).
    Loewenthal E, Weiss L, Samuel S, Or R, Slavin S.
    Bone Marrow Transplant; 1993 Aug 15; 12(2):109-13. PubMed ID: 8401354
    [Abstract] [Full Text] [Related]

  • 16. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
    Pruijt JF, Lindley IJ, Heemskerk DP, Willemze R, Fibbe WE.
    Stem Cells; 1997 Aug 15; 15(1):50-5. PubMed ID: 9007222
    [Abstract] [Full Text] [Related]

  • 17. Immunogenic and nondividing mafosfamide-treated L 1210 cells--comparison of lines resistant and nonresistant to cyclophosphamide.
    Kawalec M, Hoser G, Skórski T, Kawiak J.
    Folia Histochem Cytobiol; 1993 Aug 15; 31(2):63-6. PubMed ID: 8405569
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model.
    Jamieson C, Richter A, Levy JG.
    Exp Hematol; 1993 May 15; 21(5):629-34. PubMed ID: 8513863
    [Abstract] [Full Text] [Related]

  • 19. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T, Oh-hashi F, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1977 Apr 15; 37(4):964-8. PubMed ID: 403001
    [Abstract] [Full Text] [Related]

  • 20. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Tamayo E, Hervé P.
    Exp Hematol; 1988 Feb 15; 16(2):97-101. PubMed ID: 3276544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.